Verona Pharma Stock (NASDAQ: VRNA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 436.550K |
Day Range | - - - |
52 Wk Range | 11.830 - 23.810 |
Market Cap | $1.250B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 8.86% |
Days to Cover | 18.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Verona Pharma (NASDAQ: VRNA) through any online brokerage.
Other companies in Verona Pharma’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP), Neumora Therapeutics (NASDAQ:NMRA) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Verona Pharma (NASDAQ: VRNA) was reported by Piper Sandler on Tuesday, April 16, 2024. The analyst firm set a price target for 36.00 expecting VRNA to rise to within 12 months (a possible 123.05% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Verona Pharma (NASDAQ: VRNA) is $16.14 last updated April 24, 2024 at 5:36 PM EDT.
There are no upcoming dividends for Verona Pharma.
Verona Pharma’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Verona Pharma.
Verona Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.